ES555261A0 - Un metodo para detectar la presencia de un inhibidor de anticuerpos de factor viii humano en una muestra - Google Patents

Un metodo para detectar la presencia de un inhibidor de anticuerpos de factor viii humano en una muestra

Info

Publication number
ES555261A0
ES555261A0 ES555261A ES555261A ES555261A0 ES 555261 A0 ES555261 A0 ES 555261A0 ES 555261 A ES555261 A ES 555261A ES 555261 A ES555261 A ES 555261A ES 555261 A0 ES555261 A0 ES 555261A0
Authority
ES
Spain
Prior art keywords
sample
detecting
factor viii
human factor
antibody inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES555261A
Other languages
English (en)
Other versions
ES8801036A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of ES555261A0 publication Critical patent/ES555261A0/es
Publication of ES8801036A1 publication Critical patent/ES8801036A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/10—Factor VIII, AHF; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES555261A 1985-05-24 1986-05-23 Un metodo para detectar la presencia de un inhibidor de anticuerpos de factor viii humano en una muestra Expired ES8801036A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/738,134 US4649132A (en) 1983-03-31 1985-05-24 Treatment of Factor VIII inhibitors

Publications (2)

Publication Number Publication Date
ES555261A0 true ES555261A0 (es) 1987-12-01
ES8801036A1 ES8801036A1 (es) 1987-12-01

Family

ID=24966730

Family Applications (1)

Application Number Title Priority Date Filing Date
ES555261A Expired ES8801036A1 (es) 1985-05-24 1986-05-23 Un metodo para detectar la presencia de un inhibidor de anticuerpos de factor viii humano en una muestra

Country Status (5)

Country Link
US (1) US4649132A (es)
EP (1) EP0202853A3 (es)
JP (1) JPS6212722A (es)
AU (1) AU5730286A (es)
ES (1) ES8801036A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747337A (en) * 1983-03-31 1998-05-05 The Scripps Research Institute Factor VIII coagulant polypeptides and monoclonal antibodies to them
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
US5543145A (en) * 1984-09-17 1996-08-06 Baxter International, Inc. Pharmaceutical composition and method for the suppression of factor VIII inhibitor production
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
US5149637A (en) * 1987-04-06 1992-09-22 Scripps Clinic & Research Foundation Recombinant Factor VIIIC fragments
US4980456A (en) * 1987-04-06 1990-12-25 Scripps Clinic And Research Foundation Recombinant factor VIIIC derived fragments
AU2473388A (en) * 1987-11-16 1989-06-22 Scripps Clinic And Research Foundation Treatment of factor viii inhibitors
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
WO1990015615A1 (en) * 1989-06-20 1990-12-27 Scripps Clinic And Research Foundation The phospholipid binding domain of factor viii
WO1995003332A1 (en) * 1993-07-23 1995-02-02 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
BE1008491A3 (fr) * 1994-07-14 1996-05-07 Croix Rouge De Belgique Depart Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci.
US20020068303A1 (en) 1994-07-14 2002-06-06 Ruth Laub Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences
US5843462A (en) 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
US6057164A (en) * 1996-03-08 2000-05-02 Octapharma Ag Process for testing suitability of protein fractions containing factor VIII
EP1037663A2 (en) 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
US20040096456A1 (en) * 2000-12-01 2004-05-20 Conti-Fine Bianca M Method to treat hemophilia
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
CN116284411B (zh) * 2023-02-03 2024-02-13 北京基科晟斯医药科技有限公司 抗培重组人凝血因子VIII-Fc融合蛋白的抗体及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
EP0202853A2 (en) 1986-11-26
EP0202853A3 (en) 1988-07-20
JPS6212722A (ja) 1987-01-21
US4649132A (en) 1987-03-10
AU5730286A (en) 1986-11-27
ES8801036A1 (es) 1987-12-01

Similar Documents

Publication Publication Date Title
ES555261A0 (es) Un metodo para detectar la presencia de un inhibidor de anticuerpos de factor viii humano en una muestra
KR880700258A (ko) 중합체 경도 비파괴 측정 방법
ES541867A0 (es) Un metodo para determinar la presencia de un determinante antigenico de interleuquina-2-en una muestra.
ES553135A0 (es) Aparato y metodo correspondiente para medir continuamente gastomasico
BR8606655A (pt) Sonda de microdilatacao e sistema para realizacao de angioplastia
ES551697A0 (es) Un aparato para la comprobacion no destructiva de una pieza a comprobar o muestra
FI875445A7 (fi) Menetelmä ja laite parametrien määrittämiseksi kaasumaisia aineita varten
BR8604929A (pt) Detector de desgaste ferromagnetico e metodo para determinar o grau de desgaste
ES557662A0 (es) Un metodo y su correspondiente dispositivo para la determinacion de anticuerpos en liquidos biologicos.
ES555428A0 (es) Un metodo para ensayar cuantitativamente la proteina c en un medio que la contiene.
IT1199724B (it) Preparato per la diagnosi della funzione di trasporto della salpinge e metodo per la sua preparazione
IT1196774B (it) Procedimento per esaminare la superficie di un campione e dispositivo per la sua attuazione
IT1230554B (it) Metodo di analisi di composti organici in cromatografia e dispositivo per la sua realizzazione.
ES501734A0 (es) Un procedimiento para la deteccion de anticuerpos en una muestra de ensayo
FI896304A7 (fi) Harkkojen virheenhavaitsemismenetelmä
ES553639A0 (es) Un aparato de ensayo cuantitativo para detectar un antigeno o anticuerpo en una muestra.
ES539280A0 (es) Un dispositivo para medir la entalpia de una sustancia
FI882018L (fi) Immunologinen menetelmä intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) määrittämiseksi selektiivisesti elimistönesteistä ja väline sen toteuttamiseksi
ES545824A0 (es) Procedimiento de formacion de un material laminar para la ligacion de sustancias biologicas contenidas en una muestra analitica
ES527193A0 (es) Un metodo para determinar antigenos estreptococales en una muestra clinica
PT84504B (pt) Metodo para a deteccao de haptenos em tecnicas de imunoensaio
MX164735B (es) Un metodo para la determinacion de bilirrubina en solucion
FI922197A7 (fi) Menetelmä ihmisen T-solujen pinta-antigeenien määrittämiseksi
ES545787A0 (es) Un metodo para determinar la presencia de ige especifica en sueros humanos
IT8547849A0 (it) Detonatore ritardato e procedimento per la sua realizzazione